U.S. Food & Drug Administration (FDA)

Last month, I listened to a podcast interviewing the owner of Straight Arrow, the parent company that produces Mane and Tail and Cowboy Magic products. As a lifelong horse owner (including several grey horses that love mud), I cannot remember a time when I did not have a Mane and Tail and/or Cowboy Magic product

On October 30, 2018, the U.S. Food and Drug Administration “announced the Plant and Animal Biotechnology Innovation Action Plan to outline the key priorities the agency will pursue to support innovation in plant and animal biotechnology while advancing the agency’s public health mission. The overall goal of the action plan is to ensure the safety

In preparation for the VFD final rule, which outlines the revised process for authorizing use of VFD drugs (animal drugs intended for use in or on animal feed and that require the supervision of a licensed veterinarian), FDA released it’s final version of its industry guidance #233 titled “Veterinary Feed Directive-Common Format Questions and

FDA, gearing up for the implementation of the Veterinary Feed Directive (VFD), recently “issued a letter reminding retail establishments that sell medically important antimicrobials for use in feed or water for food animals that the marketing status of those products will change from over-the-counter (OTC) to prescription (Rx) or to veterinary feed directive (VFD)

FDA issued a draft revised guidance for industry, “General Principles for Evaluating the Human Food Safety of New Animal Drugs Used In Food-Producing Animals” in July 2016 that “described the type of information that the Food and Drug Administration’s (FDA’s) Center for Veterinary Medicine (CVM) recommends sponsors provide [the agency] to address the

While there is a dispute amongst attorneys about FDA’s authority to govern compounding in veterinary medicine in the absence of amendments to the Federal Food Drug and Cosmetic Act, there is no doubt that states may legislate or regulate this area of practice.

Compounding, defined by AVMA as “any manipulation of a drug beyond

A number of presenters at this recent conference described the landscape of federal and state oversight of veterinary drugs and therapeutics.

Here is a quick primer on the topic:

USDA’s Center for Veterinary Biologics (CVB) is authorized, under the Virus-Serum-Toxin Act (VSTA) of 1913, amended by the Food Security Act of 1985, to license and

I attended the first ever Legal, Regulatory and Compliance Forum on Animal Health and Veterinary Drugs and Therapeutics, “a comprehensive guide to the latest developments affecting drugs for companion animals and livestock,” held in New York City by the American Conference Institute, on September 10-11.

Attendees and speakers were the who’s-who of this area of

As discussed in USDA, FDA, and EPA-confusing authority over livestock production and food labeling, several federal agencies have varying control over livestock production and the food resulting therefrom.

For example, the Food Safety and Inspection Service (FSIS) in USDA is “responsible for ensuring that the nation’s commercial supply of meat, poultry, and egg products

As discussed in prior postings, there are animal and public health concerns associated with the growing practice of feeding raw food to pets.

The Centers for Disease Control (“CDC”) recently reported they will step up their efforts to study potential risks from such feeding practices.

CDC described an investigation they have begun to determine